Atria Wealth Solutions, Inc. Rvl Pharmaceuticals PLC Transaction History

Atria Wealth Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$1.02 - $1.39 $23,460 - $31,969	23,000 New	23,000 $26,000
Q4 2022 Aug 30, 2023	BUY	$1.02 - $1.61 $23,460 - $37,030	23,000 New	23,000 $25,000
Q4 2022 Feb 13, 2023	SELL	$1.02 - $1.61 $4,080 - $6,440	-4,000 Reduced 14.81%	23,000 $25,000
Q2 2022 Aug 15, 2022	SELL	$1.21 - $1.81 $10,164 - $15,204	-8,400 Reduced 23.73%	27,000 $37,000
Q1 2022 May 16, 2022	BUY	$1.03 - $2.01 $36,462 - $71,153	35,400 New	35,400 $60,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.